Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'

Autoimmun Rev. 2016 Feb;15(2):202. doi: 10.1016/j.autrev.2015.06.007. Epub 2015 Jun 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Lung Diseases, Interstitial / therapy*
  • Scleroderma, Systemic / complications*